Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients
NCT ID: NCT04368884
Last Updated: 2020-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2020-04-22
2021-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Infection in Healthcare Workers
NCT04386759
Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic
NCT04431310
Surveillance Among Healthcare Workers for SARS-Coronavirus-2 Infection
NCT05175963
COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic
NCT04304690
Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital
NCT04362267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Objectives
* To determine the extent of infection in the healthcare workers (HCW) of a tertiary care hospital in India, by determining the seropositivity
* To compare immune changes that might occur in healthcare workers who are asymptomatic or symptomatic with the proven positive cases in OPD or IPD at Max hospital.
Secondary Objectives
* To determine the fraction of asymptomatic or subclinical infections
* To understand the seroconversion status at different stages of exposure to front line HCW
The study population would include all employees of Max Hospitals, Delhi-NCR, who have been tested for COVID-19. Samples and data of the COVID positive patients admitted in the hospital will also be collected and OPD patients coming to the hospital for COVID-19 testing will be one of the study subsets.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthcare workers
The healthcare workers who are being tested for COVID-19 would be included in this group
No interventions assigned to this group
OPD patients
Individuals outside from the hospital who are coming for the COVID-19 testing will be included in this group
No interventions assigned to this group
IPD COVID-19 cases
Admitted positive cases of COVID-19 in the hospital will be included in this group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COVID-19 positive patients admitted in the hospital OR
* Out-patients getting tested for COVID-19
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Max Healthcare Insititute Limited
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sujeet Jha, MRCP (U.K)
Role: PRINCIPAL_INVESTIGATOR
Max Healthcare Institute Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Max Super Speciality Hospital, A Unit of Devki Devi Foundation
New Delhi, National Capital Territory of Delhi, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Covid-19/MHC-2/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.